跳至主要内容
临床试验/CTRI/2020/07/026517
CTRI/2020/07/026517招募中3 期

Randomized Open Controlled Clinical Study To Evaluate Efficacy Of Darvyadighanvati In Asrugdara W.S.R.To Puberty Menorrhagia

DrKavita chandrashekhar mule1 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2020年7月16日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
125
试验地点
1
主要终点
minimize exessive bloodloss in Asrugdhara (Puberty menorragia)

研究概览

简要总结

I DR. Kavita Chandrashekhar Mule Associete  Professor PrasutiTantra & Streerog Department  at YashwantAyurved College Kodoli And Registered for In service ( teacher quota) PhD Scolar At CSMSSs Ayurved Mahavidyalay Kanchanwwadi  Aurangabad  under Maharashra Univercity Of Health Sciences  Nashik.

This  Present Study is related to menstrual Problem like Ashrugdara  W>S>R>to Puberty Menorrhagia which is common gynecological   disorder that may land towards morbidity ,anemia in adolescence girls  They may stay away from schools and social functions due to inconvinance caused by excessive flow and fatigue Puberty age is step towards motherhood.

In trial drug Darvyadighanvati  an non hormonal Ayurvedic drug  will be given in Puberty menorrhagia  .

Government of India runs National Program for Child and Mother in  which identify and treatment  for  anemia  in adolescence girlis done. In puberty age anemia is mainly due to menorrhagia ,so this topic helpful to Government of India as Puberty Menorrhagia is treated with Darvyadighanvati non hormonal Ayurvedic drug.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Not Applicable

入排标准

年龄范围
13.00 Year(s) 至 19.00 Year(s)(—)
性别
Female

入选标准

  • Age 13 yrs to 19 years Patients with prolonged cycles, excessive bleeding p/v during menstruation, more than three pads Dysfunctional Uterine Bleeding Hb% 8 grams% and above.

排除标准

  • H/o Endocrinal disorders H/o Bleeding dyscrasias Intermenstrual bleeding H/o Structural abnormality in genital organs H/o Any other systemic illness H/o Genital tuberculosis PCOD Hb% < 8gm% H/o Juvenile Diabetes Mellitus.

结局指标

主要结局

minimize exessive bloodloss in Asrugdhara (Puberty menorragia)

时间窗: 15 weeks

次要结局

  • TO Minimize Excessive Blood Loss . An Alternative Hormonal Therapy In Puberty Menorrhagia(whiten three month of period)

研究者

发起方
DrKavita chandrashekhar mule
申办方类型
Other [other(self)]

研究点 (1)

Loading locations...

相似试验